“…After the decision for a new implant, the use of subcutaneous devices, such as defibrillators and pacemakers without electrodes, should be considered when available, which have shown lower rates of infections, mainly of endocarditis and sepsis. 1,[9][10][11] The various guidelines and current studies already published 1,5,6,8,[11][12][13] should serve to standardize and organize the conduct, which would lead to a lower rate of complications and mortality. SOBRAC -Brazilian Society of Cardiac Arrhythmias is finalizing its guidelines in 2021, with a broad chapter on the topic, which will help a lot in the resolution of these issues, and the Latin American Society of Cardiac Rhythm (LAHRS) has also actively participated in the recent guideline.…”